Dr. Vikas Karade in ↗
CEO & Co-founder · PhD, IIT Bombay
Product vision, clinical AI strategy, commercialization and partnerships
Company
Intelligence for
the next era
of surgery.
Patient-specific surgical AI, from medical images to robotic execution.
U.S. parent company with an Indian operating subsidiary.
Y Combinator W18Knee AI on 200+ robotsCE-marked on partner's label
Our thesis
The robot is only as intelligent as the software behind it.
Robotic hardware is maturing fast; the next race is for the intelligence behind it: understanding the anatomy, deciding the plan, mapping it to the patient and delivering it safely.
Intelligence · AlgoSurg
- AlgoSurg AI
Understand the anatomy
AI turns CT and MRI into patient-specific 3D bone, tumor and landmarks.
- AlgoSurg Plan
Decide the plan
Implants, resections or margins proposed in minutes; the surgeon approves.
- Preclinical prototypeAlgoSurg IntraOp
Map it and deliver it
Registers the approved plan to the patient and guides the robot or navigation system.
Hardware · device companiesRobots · navigation · tracking cameras · patient-specific guidesMaturing fast. AlgoSurg is hardware-agnostic, so the same intelligence runs on each.
What makes us different
Not just AI models. Surgical workflows.
AlgoSurg combines image intelligence, procedure mathematics, surgeon-facing software, device integration and productization know-how.
01
Clinical depth
Planning logic is built around real measurements, implants, resections, trajectories and workflow constraints.
02
Platform reuse
Core imaging, geometry, planning and registration infrastructure is reused across procedures.
03
Licensing model
Device companies keep their implants and hardware while licensing the intelligence layer they need.
04
Deployment evidence
Commercial planning deployment is complemented by component-level validation and controlled releases.
Milestones
From R&D to robots in the field.
From a first AI model in 2018 to software running on commercial surgical robots today.
- 2018
Y Combinator W18
Surgical AI research and platform R&D.
- 2020
DeftFix
External-fixator planning software, licensed non-exclusively to SH Pitkar; US FDA-cleared on its label.
- 2022–23
Multi-product licensing deal
Knee planning AI licensed non-exclusively to Meril.
- 2025
Knee goes commercial
Knee planning live on the MISSO robotic platform across India; the device partner's system is CE-marked under EU MDR on its label.
- 2026
Expanding
Hip in partner testing, shoulder prototype, TAVR near commercial, bone-tumor pilot, spine, CMF and dental AI.
Where we are headed
Connect pre-op intent with intra-op execution.
Pre-op AI proved the platform. Next: intra-operative guidance for bone-tumor surgery and intra-operative robotic software for the knee — connecting approved plans to registration and execution while staying hardware-agnostic. Then, closing the loop: AI that learns from every surgery.
- Today · commercial
Pre-op
Imaging, anatomy AI and a surgeon-approved plan, live in robotic knee replacement.
- Next · in development
AlgoSurg IntraOp
Tracking connectivity, patient registration, and plan verification in the OR.
- Vision · learning loop
Outcome-learning AI
AI that learns from pre-op intent, intra-op execution and post-op outcomes, so every surgery improves the next.
Founders
Founder-market fit in surgical AI and robotics.
Dr. Vikas Karade and Amit Maurya, both from IIT Bombay, founded AlgoSurg in 2018 and have led it from research to software on commercial surgical robots.
Amit Maurya in ↗
CTO & Co-founder · B.Tech, IIT Bombay
AI, product engineering, robotics, deployment and regulatory
- Y Combinator ↗W18 batch, Silicon Valley
- Plug and Play ↗MedTech accelerator
- JLABS @ TMCJohnson & Johnson Innovation, Texas Medical Center
- Intuitive FoundationDiscovery Award
Partners & investors
Interested in what we're building?
For product partnerships, strategic collaborations or company discussions, get in touch directly.